Aptevo Therapeutics Inc. Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aptevo Therapeutics Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • Aptevo Therapeutics Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 17.1M shares, a 17.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 17.1M +2.58M +17.9% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 4.08M -3.46M -45.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 673K -6.57M -90.7% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 442K -6.02M -93.2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 14.5M +9.38M +184% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 7.54M +2.45M +48.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 7.24M +2.23M +44.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 6.47M +1.57M +32% Dec 31, 2022 10-K 2024-03-05
Q3 2022 5.09M +195K +3.98% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 5.09M +205K +4.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 5.01M +558K +12.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 4.9M +487K +11% Dec 31, 2021 10-K 2023-03-30
Q3 2021 4.9M +1.66M +51.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 4.88M +1.65M +51.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 4.45M +1.22M +37.6% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 4.41M +1.18M +36.4% Dec 31, 2020 10-K 2022-03-24
Q3 2020 3.23M -42M -92.9% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 3.23M -41.9M -92.8% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 3.23M -41.9M -92.8% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 3.23M -19.6M -85.8% Dec 31, 2019 10-K 2021-03-31
Q3 2019 45.3M +22.6M +99.7% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 45.1M +22.4M +99% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 45.1M +22.6M +101% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 22.8M +1.2M +5.57% Dec 31, 2018 10-K 2020-03-25
Q3 2018 22.7M +1.25M +5.84% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 22.7M +1.36M +6.37% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 22.4M +1.22M +5.76% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 21.6M +1.33M +6.58% Dec 31, 2017 10-K 2019-03-18
Q3 2017 21.4M +1.18M +5.83% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 21.3M Jun 30, 2017 10-Q 2017-08-10
Q1 2017 21.2M Mar 31, 2017 10-Q 2017-05-12
Q4 2016 20.3M +20.3M Dec 31, 2016 10-K 2018-03-13
Q3 2016 20.2M Sep 30, 2016 10-Q 2016-11-14
Q4 2015 0 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.